Loading...
Taro Pharmaceuticals Inc., — Ras Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #16 buyer for Ras · $250.0K import value · 5 shipments · CANADA · DGFT Verified
Taro Pharmaceuticals Inc., is the #16 importer of Ras from India with $250.0K in import value and 5 verified shipments. Taro Pharmaceuticals Inc., holds a 0.1% market share in Ras imports based in CANADA. Overall, Taro Pharmaceuticals Inc., imports 12 pharmaceutical products worth $6.8M across 6 therapeutic categories.
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INTAS PHARMACEUTICALS LIMITED | $36.5M | 731 | 28 |
| MSN LABORATORIES PRIVATE LIMITED | $22.3M | 512 | 24 |
| MYLAN LABORATORIES LIMITED | $20.1M | 402 | 16 |
| CIPLA LIMITED | $8.3M | 166 | 21 |
| ALKEM LABORATORIES LIMITED | $6.9M | 138 | 6 |
| DR.REDDY'S LABORATORIES LTD | $6.0M | 119 | 12 |
| USV PRIVATE LIMITED | $4.9M | 98 | 9 |
| AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $4.5M | 91 | 1 |
| BIOCON BIOLOGICS INDIA LIMITED | $3.2M | 64 | 17 |
| MACLEODS PHARMACEUTICALS LTD | $3.2M | 64 | 9 |
India's top Ras suppliers include INTAS PHARMACEUTICALS LIMITED, MSN LABORATORIES PRIVATE LIMITED, MYLAN LABORATORIES LIMITED. These companies represent the primary source of Ras exports from India, serving buyers like Taro Pharmaceuticals Inc., in CANADA and other global markets.
What Taro Pharmaceuticals Inc., and other importers must comply with to import Ras from India
Health Canada (HC)
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
India exported $31.5M worth of Ras through 15,000 shipments from 1156 suppliers to 176 countries, serving 2,323 buyers globally. Taro Pharmaceuticals Inc., imports $250.0K of this total, accounting for 0.1% of India's Ras exports with 5 shipments from CANADA.
Taro Pharmaceuticals Inc.,'s average Ras order value is $50.0K per consignment, based on 5 shipments totaling $250.0K. Taro Pharmaceuticals Inc., is based in CANADA and ranks #16 among all Ras importers from India by value.
Top Indian Ras suppliers include INTAS PHARMACEUTICALS LIMITED ($36.5M), MSN LABORATORIES PRIVATE LIMITED ($22.3M), MYLAN LABORATORIES LIMITED ($20.1M), CIPLA LIMITED ($8.3M), ALKEM LABORATORIES LIMITED ($6.9M). These companies represent the primary source of Ras exports from India.
Taro Pharmaceuticals Inc., ranks #16 among 2,323 Ras importers from India with a 0.1% market share. The top 3 importers are MYLAN IRELAND LIMITED ($5.4M), MYLAN IRELAND LTD ($5.2M), FAWDON MAUFACTURING CENTRE (SF) ($3.5M). Taro Pharmaceuticals Inc., processed 5 shipments from CANADA.
Taro Pharmaceuticals Inc., imports 12 products worth $6.8M. Beyond Ras, top products include Temozolomide, Sunitinib, Budesonide, Dasatinib, Doxorubicin. View the complete Taro Pharmaceuticals Inc., profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Ras — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for Taro Pharmaceuticals Inc.,'s Ras imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Taro Pharmaceuticals Inc.,
Full Company Profile →
12 products · $6.8M total trade · 6 categories
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 176+ countries, 2,323+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for Taro Pharmaceuticals Inc.,.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ras. For current order-level data, contact TransData Nexus.